TY - JOUR
T1 - Improved diagnostic accuracy of SPECT through statistical analysis and the detection of hot spots at the primary sensorimotor area for the diagnosis of Alzheimer disease in a community-based study
T2 - "The Osaki-Tajiri Project"
AU - Kaneta, Tomohiro
AU - Nakatsuka, Masahiro
AU - Nakamura, Kei
AU - Seki, Takashi
AU - Yamaguchi, Satoshi
AU - Tsuboi, Masahiro
AU - Meguro, Kenichi
N1 - Publisher Copyright:
© 2015 Wolters Kluwer Health, Inc.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Purpose SPECT is an important diagnostic tool for dementia. Recently, statistical analysis of SPECT has been commonly used for dementia research. In this study, we evaluated the accuracy of visual SPECT evaluation and/or statistical analysis for the diagnosis (Dx) of Alzheimer disease (AD) and other forms of dementia in our community-based study "The Osaki-Tajiri Project." Patients and Methods Eighty-nine consecutive outpatients with dementia were enrolled and underwent brain perfusion SPECT with 99mTc-ECD. Diagnostic accuracy of SPECT was tested using 3 methods: visual inspection (SPECT Dx), automated diagnostic tool using statistical analysis with easy Z-score imaging system (eZIS Dx), and visual inspection plus eZIS (integrated Dx). Results Integrated Dx showed the highest sensitivity, specificity, and accuracy, whereas eZIS was the second most accurate method. We also observed that a higher than expected rate of SPECT images indicated false-negative cases of AD. Among these, 50% showed hypofrontality and were diagnosed as frontotemporal lobar degeneration. These cases typically showed regional "hot spots" in the primary sensorimotor cortex (ie, a sensorimotor hot spot sign), which we determined were associated with AD rather than frontotemporal lobar degeneration. Conclusion We concluded that the diagnostic abilities were improved by the integrated use of visual assessment and statistical analysis. In addition, the detection of a sensorimotor hot spot sign was useful to detect AD when hypofrontality is present and improved the ability to properly diagnose AD.
AB - Purpose SPECT is an important diagnostic tool for dementia. Recently, statistical analysis of SPECT has been commonly used for dementia research. In this study, we evaluated the accuracy of visual SPECT evaluation and/or statistical analysis for the diagnosis (Dx) of Alzheimer disease (AD) and other forms of dementia in our community-based study "The Osaki-Tajiri Project." Patients and Methods Eighty-nine consecutive outpatients with dementia were enrolled and underwent brain perfusion SPECT with 99mTc-ECD. Diagnostic accuracy of SPECT was tested using 3 methods: visual inspection (SPECT Dx), automated diagnostic tool using statistical analysis with easy Z-score imaging system (eZIS Dx), and visual inspection plus eZIS (integrated Dx). Results Integrated Dx showed the highest sensitivity, specificity, and accuracy, whereas eZIS was the second most accurate method. We also observed that a higher than expected rate of SPECT images indicated false-negative cases of AD. Among these, 50% showed hypofrontality and were diagnosed as frontotemporal lobar degeneration. These cases typically showed regional "hot spots" in the primary sensorimotor cortex (ie, a sensorimotor hot spot sign), which we determined were associated with AD rather than frontotemporal lobar degeneration. Conclusion We concluded that the diagnostic abilities were improved by the integrated use of visual assessment and statistical analysis. In addition, the detection of a sensorimotor hot spot sign was useful to detect AD when hypofrontality is present and improved the ability to properly diagnose AD.
KW - Alzheimer disease
KW - SPECT
KW - dementia
KW - easy Z -score imaging system
UR - http://www.scopus.com/inward/record.url?scp=84951907094&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84951907094&partnerID=8YFLogxK
U2 - 10.1097/RLU.0000000000000976
DO - 10.1097/RLU.0000000000000976
M3 - Article
C2 - 26359573
AN - SCOPUS:84951907094
SN - 0363-9762
VL - 41
SP - e1-e6
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
IS - 1
ER -